The African network for improved diagnostics, epidemiology and management of common infectious agents

dc.contributor.authorSchubert, Grit
dc.contributor.authorAchi, Vincent
dc.contributor.authorAhuka, Steve
dc.contributor.authorBelarbi, Essia
dc.contributor.authorBourhaima, Ouattara
dc.contributor.authorEckmanns, Tim
dc.contributor.authorJohnstone, Siobhan L.
dc.contributor.authorKabore, Firmin
dc.contributor.authorKra, Ouffoue
dc.contributor.authorMendes, Adriano
dc.contributor.authorOuedraogo, Abdoul-Salam
dc.contributor.authorPoda, Armel
dc.contributor.authorSome, Arsene Satouro
dc.contributor.authorTomczyk, Sara
dc.contributor.authorCouacy-Hymann, Emmanuel
dc.contributor.authorKayembe, Jean-Marie
dc.contributor.authorMeda, Nicolas
dc.contributor.authorTamfum, Jean-Jacques Muyembe
dc.contributor.authorOuangraoua, Soumeya
dc.contributor.authorPage, Nicola Anne
dc.contributor.authorVenter, Marietjie
dc.contributor.authorLeendertz, Fabian H.
dc.contributor.authorAkoua-Koffi, Chantal
dc.date.accessioned2022-02-09T09:11:27Z
dc.date.available2022-02-09T09:11:27Z
dc.date.issued2021-06-07
dc.description.abstractBACKGROUND : In sub-Saharan Africa, acute respiratory infections (ARI), acute gastrointestinal infections (GI) and acute febrile disease of unknown cause (AFDUC) have a large disease burden, especially among children, while respective aetiologies often remain unresolved. The need for robust infectious disease surveillance to detect emerging pathogens along with common human pathogens has been highlighted by the ongoing novel coronavirus disease 2019 (COVID-19) pandemic. The African Network for Improved Diagnostics, Epidemiology and Management of Common Infectious Agents (ANDEMIA) is a sentinel surveillance study on the aetiology and clinical characteristics of ARI, GI and AFDUC in sub-Saharan Africa. METHODS : ANDEMIA includes 12 urban and rural health care facilities in four African countries (Côte d’Ivoire, Burkina Faso, Democratic Republic of the Congo and Republic of South Africa). It was piloted in 2018 in Côte d’Ivoire and the initial phase will run from 2019 to 2021. Case definitions for ARI, GI and AFDUC were established, as well as syndromespecific sampling algorithms including the collection of blood, naso- and oropharyngeal swabs and stool. Samples are tested using comprehensive diagnostic protocols, ranging from classic bacteriology and antimicrobial resistance screening to multiplex real-time polymerase chain reaction (PCR) systems and High Throughput Sequencing. In March 2020, PCR testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and analysis of full genomic information was included in the study. Standardised questionnaires collect relevant clinical, demographic, socioeconomic and behavioural data for epidemiologic analyses. Controls are enrolled over a 12-month period for a nested case-control study. Data will be assessed descriptively and aetiologies will be evaluated using a latent class analysis among cases. Among cases and controls, an integrated analytic approach using logistic regression and Bayesian estimation will be employed to improve the assessment of aetiology and associated risk factors. DISCUSSION : ANDEMIA aims to expand our understanding of ARI, GI and AFDUC aetiologies in sub-Saharan Africa using a comprehensive laboratory diagnostics strategy. It will foster early detection of emerging threats and continued monitoring of important common pathogens. The network collaboration will be strengthened and site diagnostic capacities will be reinforced to improve quality management and patient care.en_ZA
dc.description.departmentMedical Virologyen_ZA
dc.description.librarianam2022en_ZA
dc.description.sponsorshipThe German Federal Ministry of Education and Research. Open Access funding enabled and organized by Projekt DEAL.en_ZA
dc.description.urihttps://bmcinfectdis.biomedcentral.comen_ZA
dc.identifier.citationSchubert, G., Achi, V., Ahuka, S. et al. 2021, 'The african network for improved diagnostics, epidemiology and management of common infectious agents', BMC Infectious Diseases, vol. 21, art. 539, pp. 1-10.en_ZA
dc.identifier.issn1471-2334 (online)
dc.identifier.other10.1186/s12879-021-06238-w
dc.identifier.urihttp://hdl.handle.net/2263/83704
dc.language.isoenen_ZA
dc.publisherBioMed Centralen_ZA
dc.rights© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License.en_ZA
dc.subjectAcute gastrointestinal infectionsen_ZA
dc.subjectSentinel surveillanceen_ZA
dc.subjectAetiologiesen_ZA
dc.subjectOutbreak detectionen_ZA
dc.subjectAntimicrobial resistanceen_ZA
dc.subjectCoronavirus disease 2019 (COVID-19)en_ZA
dc.subjectCOVID-19 pandemicen_ZA
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)en_ZA
dc.subjectSub-Saharan Africa (SSA)en_ZA
dc.subjectAcute respiratory infection (ARI)en_ZA
dc.subjectAcute febrile disease of unknown cause (AFDUC)en_ZA
dc.titleThe African network for improved diagnostics, epidemiology and management of common infectious agentsen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Schubert_African_2021.pdf
Size:
1.65 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: